Literature DB >> 24284645

Predictors of persistent psychotic symptoms in persons with methamphetamine abuse receiving psychiatric treatment.

Tania Lecomte1, Kim T Mueser, William MacEwan, Allen E Thornton, Tari Buchanan, Vanessa Bouchard, Elliot Goldner, Johann Brink, Donna Lang, Shimi Kang, Alasdair M Barr, William G Honer.   

Abstract

The objective of this study was to identify predictors of sustained psychotic symptoms after methamphetamine (MA) abuse during the course of 6 months from patterns of MA and other substance use, depressive symptoms, family history of psychosis, antisocial personality disorder, and trauma history. A total of 295 individuals with MA abuse and psychotic symptoms seeking psychiatric services were assessed at baseline and then monthly on symptoms and substance use for 6 months. Trajectory analyses revealed two trajectories of the individuals with positive symptoms, with one group presenting with persistent psychotic symptoms (30% of the sample). Those with persistent psychosis were significantly older, had more severe psychotic symptoms, misused MA for more years, had more antisocial personality traits, and had more sustained depressive symptoms. The strongest predictors of belonging to the persistent psychosis group, via logistic regressions, were more severe psychotic symptoms, longer use of MA, and sustained depressive symptoms. Our results highlight the important comorbidities, especially regarding depressive symptoms and persistent psychosis, in individuals seeking psychiatric help after MA abuse. This study also highlights the importance of identifying people with persistent psychosis within MA users to facilitate rapid and effective treatment of co-occurring psychotic disorder.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24284645     DOI: 10.1097/NMD.0000000000000059

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  13 in total

1.  A comparison of regional brain volumes and white matter connectivity in subjects with stimulant induced psychosis versus schizophrenia.

Authors:  Peter D Alexander; Kristina M Gicas; Alex Cheng; Donna J Lang; Ric M Procyshyn; Alexandra T Vertinsky; William J Panenka; Allen E Thornton; Alexander Rauscher; Jamie Y X Wong; Tasha Chan; Andrea A Jones; F Vila-Rodriguez; William G Honer; Alasdair M Barr
Journal:  Psychopharmacology (Berl)       Date:  2019-06-22       Impact factor: 4.530

2.  A comparison of psychotic symptoms in subjects with methamphetamine versus cocaine dependence.

Authors:  Peter D Alexander; Kristina M Gicas; Taylor S Willi; Clara N Kim; Veronika Boyeva; Ric M Procyshyn; Geoff N Smith; Allen E Thornton; William J Panenka; Andrea A Jones; Fidel Vila-Rodriguez; Donna J Lang; G William MacEwan; William G Honer; Alasdair M Barr
Journal:  Psychopharmacology (Berl)       Date:  2017-02-11       Impact factor: 4.530

3.  Exacerbation of Methamphetamine Neurotoxicity in Cold and Hot Environments: Neuroprotective Effects of an Antioxidant Compound H-290/51.

Authors:  Hari Shanker Sharma; Eugene A Kiyatkin; Ranjana Patnaik; José Vicente Lafuente; Dafin F Muresanu; Per-Ove Sjöquist; Aruna Sharma
Journal:  Mol Neurobiol       Date:  2015-06-26       Impact factor: 5.590

4.  The impact of age, HIV serostatus and seroconversion on methamphetamine use.

Authors:  Jessica L Montoya; Jordan Cattie; Erin Morgan; Steven Paul Woods; Mariana Cherner; David J Moore; J Hampton Atkinson; Igor Grant
Journal:  Am J Drug Alcohol Abuse       Date:  2016-02-02       Impact factor: 3.829

5.  Clinical features, course and treatment of methamphetamine-induced psychosis in psychiatric inpatients.

Authors:  Homa Zarrabi; Mohammadrasoul Khalkhali; Azam Hamidi; Reza Ahmadi; Maryam Zavarmousavi
Journal:  BMC Psychiatry       Date:  2016-02-25       Impact factor: 3.630

6.  Comparison of demographic characteristics and psychiatric comorbidity among methamphetamine-, heroin- and methamphetamine-heroin co- dependent males in Hunan, China.

Authors:  Huixi Dong; Mei Yang; Liang Liu; Chenxi Zhang; Mengqi Liu; Yidong Shen; Huanzhong Liu; Wei Hao
Journal:  BMC Psychiatry       Date:  2017-05-12       Impact factor: 3.630

Review 7.  A Review of Risk Factors for Methamphetamine-Related Psychiatric Symptoms.

Authors:  Xiangwen Chang; Yan Sun; Yang Zhang; Jiana Muhai; Lin Lu; Jie Shi
Journal:  Front Psychiatry       Date:  2018-11-16       Impact factor: 4.157

8.  A Study of the Prevalence of Psychiatric Disorders in Patients with Methamphetamine-Induced Psychosis.

Authors:  Mahin Eslami-Shahrbabaki; Alireza Fekrat; Shahrzad Mazhari
Journal:  Addict Health       Date:  2015 Winter-Spring

9.  Epidemiological Characteristics and Risk Factors of Methamphetamine-Associated Psychotic Symptoms.

Authors:  Meng-Fan Su; Mo-Xuan Liu; Jin-Qiao Li; Julia M Lappin; Su-Xia Li; Ping Wu; Zhi-Min Liu; Jie Shi; Lin Lu; Yanping Bao
Journal:  Front Psychiatry       Date:  2018-10-12       Impact factor: 4.157

10.  Aberrant Resting-State Cerebellar-Cerebral Functional Connectivity in Methamphetamine-Dependent Individuals After Six Months Abstinence.

Authors:  Xiaotong Li; Hang Su; Na Zhong; Tianzhen Chen; Jiang Du; Ke Xiao; Ding Xu; Weidong Song; Haifeng Jiang; Min Zhao
Journal:  Front Psychiatry       Date:  2020-03-31       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.